Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1180

1.

Remote sensing of cyanobacterial blooms in a hypertrophic lagoon (Albufera of València, Eastern Iberian Peninsula) using multitemporal Sentinel-2 images.

Sòria-Perpinyà X, Vicente E, Urrego P, Pereira-Sandoval M, Ruíz-Verdú A, Delegido J, Soria JM, Moreno J.

Sci Total Environ. 2019 Sep 4;698:134305. doi: 10.1016/j.scitotenv.2019.134305. [Epub ahead of print]

PMID:
31514039
2.

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade.

Jacquelot N, Yamazaki T, Roberti MP, Duong CPM, Andrews MC, Verlingue L, Ferrere G, Becharef S, Vétizou M, Daillère R, Messaoudene M, Enot DP, Stoll G, Ugel S, Marigo I, Foong Ngiow S, Marabelle A, Prevost-Blondel A, Gaudreau PO, Gopalakrishnan V, Eggermont AM, Opolon P, Klein C, Madonna G, Ascierto PA, Sucker A, Schadendorf D, Smyth MJ, Soria JC, Kroemer G, Bronte V, Wargo J, Zitvogel L.

Cell Res. 2019 Sep 3. doi: 10.1038/s41422-019-0224-x. [Epub ahead of print]

PMID:
31481761
3.

An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.

Faugeroux V, Lefebvre C, Pailler E, Pierron V, Marcaillou C, Tourlet S, Billiot F, Dogan S, Oulhen M, Vielh P, Rameau P, NgoCamus M, Massard C, Laplace-Builhé C, Tibbe A, Taylor M, Soria JC, Fizazi K, Loriot Y, Julien S, Farace F.

Eur Urol Oncol. 2019 Jan 4. pii: S2588-9311(18)30213-X. doi: 10.1016/j.euo.2018.12.005. [Epub ahead of print]

PMID:
31412010
4.

Corrigendum to 'A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours' [Eur J Cancer 104 (November 2018) 1-8].

Gazzah A, Boni V, Soria JC, Calles A, Even C, Doger B, Mahjoubi L, Bahleda R, Ould-Kaci M, Esler A, Nazabadioko S, Calvo E.

Eur J Cancer. 2019 Jul 30. pii: S0959-8049(18)31564-8. doi: 10.1016/j.ejca.2018.12.018. [Epub ahead of print] No abstract available.

PMID:
31375258
5.

Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma.

Gluck WL, Gounder MM, Frank R, Eskens F, Blay JY, Cassier PA, Soria JC, Chawla S, de Weger V, Wagner AJ, Siegel D, De Vos F, Rasmussen E, Henary HA.

Invest New Drugs. 2019 Jul 29. doi: 10.1007/s10637-019-00840-1. [Epub ahead of print]

PMID:
31359240
6.

Author Correction: Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B, Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F.

Nature. 2019 Aug;572(7767):E7. doi: 10.1038/s41586-019-1380-3.

PMID:
31308536
7.

Optimizing oncolytic virotherapy in cancer treatment.

Harrington K, Freeman DJ, Kelly B, Harper J, Soria JC.

Nat Rev Drug Discov. 2019 Sep;18(9):689-706. doi: 10.1038/s41573-019-0029-0. Epub 2019 Jul 10. Review.

PMID:
31292532
8.

Influence of ABO Locus on PFA-100 Collagen-ADP Closure Time Is Not Totally Dependent on the Von Willebrand Factor. Results of a GWAS on GAIT-2 Project Phenotypes.

Pujol-Moix N, Martinez-Perez A, Sabater-Lleal M, Llobet D, Vilalta N, Hamsten A, Souto JC, Soria JM.

Int J Mol Sci. 2019 Jun 30;20(13). pii: E3221. doi: 10.3390/ijms20133221.

9.

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.

Lindsay CR, Blackhall FH, Carmel A, Fernandez-Gutierrez F, Gazzaniga P, Groen HJM, Hiltermann TJN, Krebs MG, Loges S, López-López R, Muinelo-Romay L, Pantel K, Priest L, Riethdorf S, Rossi E, Terstappen L, Wikman H, Soria JC, Farace F, Renehan A, Dive C, Besse B, Michiels S.

Eur J Cancer. 2019 Aug;117:60-68. doi: 10.1016/j.ejca.2019.04.019. Epub 2019 Jun 27.

10.

Importance of clot permeability and clot degradability for determination of rivaroxaban efficacy.

Mirshahi S, Varin R, Soria J.

Pol Arch Intern Med. 2019 Jun 28;129(6):367-369. doi: 10.20452/pamw.14884. Epub 2019 Jun 28. No abstract available.

11.

Influence of Post-Synthesis Modifications of Ti1-xZrxO₂ Nanocrystallites on Their Photocatalytic Activity for Toluene and Methylcyclohexane Degradation.

Hernández-Alonso MD, Fresno F, de la Peña O'Shea VA, Soria J, Coronado JM.

J Nanosci Nanotechnol. 2019 Dec 1;19(12):7810-7818. doi: 10.1166/jnn.2019.16738.

PMID:
31196293
12.

Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.

Kundu K, Ghosh S, Sarkar R, Edri A, Brusilovsky M, Gershoni-Yahalom O, Yossef R, Shemesh A, Soria JC, Lazar V, Joshua BZ, Campbell KS, Elkabets M, Porgador A.

Cancer Immunol Res. 2019 Jul;7(7):1120-1134. doi: 10.1158/2326-6066.CIR-19-0023. Epub 2019 Jun 4.

PMID:
31164357
13.

Beyond DNA repair: the novel immunological potential of PARP inhibitors.

Chabanon RM, Soria JC, Lord CJ, Postel-Vinay S.

Mol Cell Oncol. 2019 Mar 13;6(2):1585170. doi: 10.1080/23723556.2019.1585170. eCollection 2019.

PMID:
31131303
14.

Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B, Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F.

Nature. 2019 May;569(7757):560-564. doi: 10.1038/s41586-019-1056-z. Epub 2019 May 22. Erratum in: Nature. 2019 Aug;572(7767):E7.

PMID:
31118521
15.

Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor.

Henon C, Blay JY, Massard C, Mir O, Bahleda R, Dumont S, Postel-Vinay S, Adam J, Soria JC, Le Cesne A.

Ann Oncol. 2019 May 22. pii: mdz160. doi: 10.1093/annonc/mdz160. [Epub ahead of print] No abstract available.

PMID:
31114851
16.

Recurrent Miscarriage and Implantation Failure of Unknown Cause Studied by a Panel of Thrombophilia Conditions: Increased Frequency of FXIII Val34Leu Polymorphism.

Diaz-Nuñez M, Rabanal A, Expósito A, Ferrando M, Quintana F, Soria JM, Matorras R.

J Reprod Infertil. 2019 Apr-Jun;20(2):76-82.

17.

Fibrinogen αC domain: Its importance in physiopathology.

Soria J, Mirshahi S, Mirshahi SQ, Varin R, Pritchard LL, Soria C, Mirshahi M.

Res Pract Thromb Haemost. 2019 Feb 15;3(2):173-183. doi: 10.1002/rth2.12183. eCollection 2019 Apr. Review.

18.

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.

Rodon J, Soria JC, Berger R, Miller WH, Rubin E, Kugel A, Tsimberidou A, Saintigny P, Ackerstein A, Braña I, Loriot Y, Afshar M, Miller V, Wunder F, Bresson C, Martini JF, Raynaud J, Mendelsohn J, Batist G, Onn A, Tabernero J, Schilsky RL, Lazar V, Lee JJ, Kurzrock R.

Nat Med. 2019 May;25(5):751-758. doi: 10.1038/s41591-019-0424-4. Epub 2019 Apr 22.

PMID:
31011205
19.

Immune reconstitution inflammatory syndrome associated with secondary syphilis: dermatologic, neurologic and ophthalmologic compromise in an HIV patient.

Alcedo S, Newby R, José Montenegro J, Rondan P, Arevalo J, Chiappe A, Soria J.

Int J STD AIDS. 2019 Apr;30(5):509-511. doi: 10.1177/0956462418813045. Epub 2019 Jan 10.

PMID:
30999832
20.

A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.

Mak G, Soria JC, Blagden SP, Plummer R, Fleming RA, Nebot N, Zhang J, Mazumdar J, Rogan D, Gazzah A, Rizzuto I, Greystoke A, Yan L, Tolson J, Auger KR, Arkenau HT.

Br J Cancer. 2019 May;120(10):975-981. doi: 10.1038/s41416-019-0452-3. Epub 2019 Apr 17.

21.

Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index.

Coats S, Williams M, Kebble B, Dixit R, Tseng L, Yao NS, Tice DA, Soria JC.

Clin Cancer Res. 2019 Sep 15;25(18):5441-5448. doi: 10.1158/1078-0432.CCR-19-0272. Epub 2019 Apr 12. Review.

PMID:
30979742
22.

Assessment of Toxic Effects of Ochratoxin A in Human Embryonic Stem Cells.

Erceg S, Mateo EM, Zipancic I, Rodríguez Jiménez FJ, Pérez Aragó MA, Jiménez M, Soria JM, Garcia-Esparza MÁ.

Toxins (Basel). 2019 Apr 10;11(4). pii: E217. doi: 10.3390/toxins11040217.

23.

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma.

Even C, Lassen U, Merchan J, Le Tourneau C, Soria JC, Ferte C, Ricci F, Diener JT, Yuen E, Smith C, Oakley GJ 3rd, Benhadji KA, Massard C.

Invest New Drugs. 2019 Apr 6. doi: 10.1007/s10637-019-00739-x. [Epub ahead of print]

PMID:
30953269
24.

First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma.

Massard C, Soria JC, Krauss J, Gordon M, Lockhart AC, Rasmussen E, Upreti VV, Patel S, Ngarmchamnanrith G, Henary H.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1057-1063. doi: 10.1007/s00280-019-03796-4. Epub 2019 Mar 26.

PMID:
30915497
25.

Factors Associated with HIV Viral Suppression Among Transgender Women in Lima, Peru.

Rich KM, Wickersham JA, Valencia Huamaní J, Kiani SN, Cabello R, Elish P, Florez Arce J, Pizzicato LN, Soria J, Sanchez J, Altice FL.

LGBT Health. 2018 Nov/Dec;5(8):477-483. doi: 10.1089/lgbt.2017.0186.

26.

Moving from academia to industry in the field of oncology.

Soria JC.

Clin Adv Hematol Oncol. 2019 Jan;17(1):38-39. No abstract available.

PMID:
30843896
27.

Changes in tear biomarker levels in keratoconus after corneal collagen crosslinking.

Recalde JI, Duran JA, Rodriguez-Agirretxe I, Soria J, Sanchez-Tena MA, Pereiro X, Suarez T, Acera A.

Mol Vis. 2019 Jan 20;25:12-21. eCollection 2019.

28.

Renal toxicities associated with pembrolizumab.

Izzedine H, Mathian A, Champiat S, Picard C, Mateus C, Routier E, Varga A, Malka D, Leary A, Michels J, Michot JM, Marabelle A, Lambotte O, Amoura Z, Soria JC, Kaaki S, Quellard N, Goujon JM, Brocheriou I.

Clin Kidney J. 2019 Feb;12(1):81-88. doi: 10.1093/ckj/sfy100. Epub 2018 Nov 9.

29.

The "Guardian of the Genome"-An Old Key to Unlock the ERCC1 Issue.

Friboulet L, Soria JC, Olaussen KA.

Clin Cancer Res. 2019 Apr 15;25(8):2369-2371. doi: 10.1158/1078-0432.CCR-18-4123. Epub 2019 Feb 6.

PMID:
30728154
30.

First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity.

Postel-Vinay S, Herbschleb K, Massard C, Woodcock V, Soria JC, Walter AO, Ewerton F, Poelman M, Benson N, Ocker M, Wilkinson G, Middleton M.

Eur J Cancer. 2019 Mar;109:103-110. doi: 10.1016/j.ejca.2018.12.020. Epub 2019 Jan 31.

PMID:
30711772
31.

Progesterone anti-inflammatory properties in hereditary retinal degeneration.

Benlloch-Navarro S, Trachsel-Moncho L, Fernández-Carbonell Á, Olivar T, Soria JM, Almansa I, Miranda M.

J Steroid Biochem Mol Biol. 2019 May;189:291-301. doi: 10.1016/j.jsbmb.2019.01.007. Epub 2019 Jan 14.

PMID:
30654106
32.

A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.

de Vries PS, Sabater-Lleal M, Huffman JE, Marten J, Song C, Pankratz N, Bartz TM, de Haan HG, Delgado GE, Eicher JD, Martinez-Perez A, Ward-Caviness CK, Brody JA, Chen MH, de Maat MPM, Frånberg M, Gill D, Kleber ME, Rivadeneira F, Soria JM, Tang W, Tofler GH, Uitterlinden AG, van Hylckama Vlieg A, Seshadri S, Boerwinkle E, Davies NM, Giese AK, Ikram MK, Kittner SJ, McKnight B, Psaty BM, Reiner AP, Sargurupremraj M, Taylor KD; INVENT Consortium; MEGASTROKE Consortium of the International Stroke Genetics Consortium, Fornage M, Hamsten A, März W, Rosendaal FR, Souto JC, Dehghan A, Johnson AD, Morrison AC, O'Donnell CJ, Smith NL.

Blood. 2019 Feb 28;133(9):967-977. doi: 10.1182/blood-2018-05-849240. Epub 2019 Jan 14.

PMID:
30642921
33.

Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer.

Martinez P, Peters S, Stammers T, Soria JC.

Clin Cancer Res. 2019 May 1;25(9):2691-2698. doi: 10.1158/1078-0432.CCR-18-3904. Epub 2019 Jan 14. Review.

PMID:
30642913
34.

Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.

Soria JC, Cortes J, Massard C, Armand JP, Andreis D, Ropert S, Lopez E, Catteau A, James J, Marier JF, Beliveau M, Martell RE, Baselga J.

Ann Oncol. 2019 Jan 9. doi: 10.1093/annonc/mdy532. [Epub ahead of print] No abstract available.

PMID:
30624604
35.

Mortality in hospitalized patients with tuberculous meningitis.

Soria J, Metcalf T, Mori N, Newby RE, Montano SM, Huaroto L, Ticona E, Zunt JR.

BMC Infect Dis. 2019 Jan 5;19(1):9. doi: 10.1186/s12879-018-3633-4.

36.

Macro-TGA steam-assisted gasification of lignocellulosic wastes.

Fernandez A, Soria J, Rodriguez R, Baeyens J, Mazza G.

J Environ Manage. 2019 Mar 1;233:626-635. doi: 10.1016/j.jenvman.2018.12.087. Epub 2018 Dec 31.

PMID:
30599415
37.

Immunothérapie des glioblastomes.

Baldini C, Romano PM, Varga A, Champiat S, Dumont S, Dhermain F, Louvel G, Marabelle A, Postel-Vinay S, Angevin E, Gazzah A, Ribrag V, Bahleda R, Michot JM, Hollebecque A, Soria JC, Massard C.

Bull Cancer. 2018 Dec;105 Suppl 1:S59-S67. doi: 10.1016/S0007-4551(18)30391-6. Review. French.

PMID:
30595200
38.

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.

Chabanon RM, Muirhead G, Krastev DB, Adam J, Morel D, Garrido M, Lamb A, Hénon C, Dorvault N, Rouanne M, Marlow R, Bajrami I, Cardeñosa ML, Konde A, Besse B, Ashworth A, Pettitt SJ, Haider S, Marabelle A, Tutt AN, Soria JC, Lord CJ, Postel-Vinay S.

J Clin Invest. 2019 Mar 1;129(3):1211-1228. doi: 10.1172/JCI123319. Epub 2019 Feb 11.

39.

Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.

Sabater-Lleal M, Huffman JE, de Vries PS, Marten J, Mastrangelo MA, Song C, Pankratz N, Ward-Caviness CK, Yanek LR, Trompet S, Delgado GE, Guo X, Bartz TM, Martinez-Perez A, Germain M, de Haan HG, Ozel AB, Polasek O, Smith AV, Eicher JD, Reiner AP, Tang W, Davies NM, Stott DJ, Rotter JI, Tofler GH, Boerwinkle E, de Maat MPM, Kleber ME, Welsh P, Brody JA, Chen MH, Vaidya D, Soria JM, Suchon P, van Hylckama Vlieg A, Desch KC, Kolcic I, Joshi PK, Launer LJ, Harris TB, Campbell H, Rudan I, Becker DM, Li JZ, Rivadeneira F, Uitterlinden AG, Hofman A, Franco OH, Cushman M, Psaty BM, Morange PE, McKnight B, Chong MR, Fernandez-Cadenas I, Rosand J, Lindgren A; INVENT Consortium; MEGASTROKE Consortium of the International Stroke Genetics Consortium (ISGC), Gudnason V, Wilson JF, Hayward C, Ginsburg D, Fornage M, Rosendaal FR, Souto JC, Becker LC, Jenny NS, März W, Jukema JW, Dehghan A, Trégouët DA, Morrison AC, Johnson AD, O'Donnell CJ, Strachan DP, Lowenstein CJ, Smith NL.

Circulation. 2019 Jan 29;139(5):620-635. doi: 10.1161/CIRCULATIONAHA.118.034532.

40.

Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru.

Soria J, Mugruza R, Levine M, León SR, Arévalo J, Ticona E, Beck IA, Frenkel LM.

AIDS Res Hum Retroviruses. 2019 Feb;35(2):150-154. doi: 10.1089/AID.2018.0239. Epub 2019 Jan 22.

PMID:
30560685
41.

T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028.

Ott PA, Bang YJ, Piha-Paul SA, Razak ARA, Bennouna J, Soria JC, Rugo HS, Cohen RB, O'Neil BH, Mehnert JM, Lopez J, Doi T, van Brummelen EMJ, Cristescu R, Yang P, Emancipator K, Stein K, Ayers M, Joe AK, Lunceford JK.

J Clin Oncol. 2019 Feb 1;37(4):318-327. doi: 10.1200/JCO.2018.78.2276. Epub 2018 Dec 13.

PMID:
30557521
42.

Building a network for multicenter, prospective research of central nervous system infections in South America: Process and lessons learned.

Nelson C, Mori N, Ton T, Zunt J; Meningoencephalitis Working Group, Kochel T, Romero A, Gadea N, Tilley D, Ticona E, Soria J, Celis V, Huanca D, Delgado A, Rivas M, Stiglich M, Sihuincha M, Donayre G, Celis J, Romero R, Tam N, Tipismana M, Espinoza I, Rozas M, Peralta A, Sanchez E, Vasquez L, Muñoz P, Ramirez G, Reyes I.

eNeurologicalSci. 2018 Jul 4;13:63-69. doi: 10.1016/j.ensci.2018.07.001. eCollection 2018 Dec.

43.

Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours.

Durgeau A, Virk Y, Gros G, Voilin E, Corgnac S, Djenidi F, Salmon J, Adam J, de Montpréville V, Validire P, Ferrone S, Chouaib S, Eggermont A, Soria JC, Lemonnier F, Tartour E, Chaput N, Besse B, Mami-Chouaib F.

Nat Commun. 2018 Nov 30;9(1):5097. doi: 10.1038/s41467-018-07603-1.

44.

The size dependant behaviour of particles driven by a travelling surface acoustic wave (TSAW).

Fakhfouri A, Devendran C, Ahmed A, Soria J, Neild A.

Lab Chip. 2018 Dec 4;18(24):3926-3938. doi: 10.1039/c8lc01155a.

PMID:
30474095
45.

Salivary immunity and lower respiratory tract infections in non-elite marathon runners.

Cantó E, Roca E, Perea L, Rodrigo-Troyano A, Suarez-Cuartin G, Giner J, Feliu A, Soria JM, Nescolarde L, Vidal S, Sibila O.

PLoS One. 2018 Nov 21;13(11):e0206059. doi: 10.1371/journal.pone.0206059. eCollection 2018.

46.

LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer.

Seymour L, Le Teuff G, Brambilla E, Shepherd FA, Soria JC, Kratzke R, Graziano S, Douillard JY, Rosell R, Reiman A, Lacas B, Lueza B, Aviel-Ronen S, McLeer A, Le Chevalier T, Pirker R, Filipits M, Dunant A, Pignon JP, Tsao MS; LACE-Bio Steering Committee.

Clin Lung Cancer. 2019 Mar;20(2):66-73.e6. doi: 10.1016/j.cllc.2018.10.001. Epub 2018 Oct 11.

PMID:
30414783
47.

Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers.

Soria JA, Huisa BN, Edland SD, Litvan I, Peavy GM, Salmon DP, Hansen LA, Galasko DR, Brewer JB, González HM, Rissman RA.

J Alzheimers Dis. 2018;66(4):1539-1548. doi: 10.3233/JAD-180789.

PMID:
30412501
48.

Hyperprogressive disease: recognizing a novel pattern to improve patient management.

Champiat S, Ferrara R, Massard C, Besse B, Marabelle A, Soria JC, Ferté C.

Nat Rev Clin Oncol. 2018 Dec;15(12):748-762. doi: 10.1038/s41571-018-0111-2. Review.

PMID:
30361681
49.

The Messinian stromatolites of the Sierra del Colmenar (Western Mediterranean): facies characterization and sedimentological interpretation.

Villafañe PG, Corbí H, Cónsole-Gonella C, Ruiz-Sánchez FJ, Soria JM.

PeerJ. 2018 Oct 16;6:e5766. doi: 10.7717/peerj.5766. eCollection 2018.

50.

A European Multi Lake Survey dataset of environmental variables, phytoplankton pigments and cyanotoxins.

Mantzouki E, Campbell J, van Loon E, Visser P, Konstantinou I, Antoniou M, Giuliani G, Machado-Vieira D, Gurjão de Oliveira A, Maronić DŠ, Stević F, Pfeiffer TŽ, Vucelić IB, Žutinić P, Udovič MG, Plenković-Moraj A, Tsiarta N, Bláha L, Geriš R, Fránková M, Christoffersen KS, Warming TP, Feldmann T, Laas A, Panksep K, Tuvikene L, Kangro K, Häggqvist K, Salmi P, Arvola L, Fastner J, Straile D, Rothhaupt KO, Fonvielle J, Grossart HP, Avagianos C, Kaloudis T, Triantis T, Zervou SK, Hiskia A, Gkelis S, Panou M, McCarthy V, Perello VC, Obertegger U, Boscaini A, Flaim G, Salmaso N, Cerasino L, Koreivienė J, Karosienė J, Kasperovičienė J, Savadova K, Vitonytė I, Haande S, Skjelbred B, Grabowska M, Karpowicz M, Chmura D, Nawrocka L, Kobos J, Mazur-Marzec H, Alcaraz-Párraga P, Wilk-Woźniak E, Krztoń W, Walusiak E, Gagala I, Mankiewicz-Boczek J, Toporowska M, Pawlik-Skowronska B, Niedźwiecki M, Pęczuła W, Napiórkowska-Krzebietke A, Dunalska J, Sieńska J, Szymański D, Kruk M, Budzyńska A, Goldyn R, Kozak A, Rosińska J, Szeląg-Wasielewska E, Domek P, Jakubowska-Krepska N, Kwasizur K, Messyasz B, Pełechata A, Pełechaty M, Kokocinski M, Madrecka B, Kostrzewska-Szlakowska I, Frąk M, Bańkowska-Sobczak A, Wasilewicz M, Ochocka A, Pasztaleniec A, Jasser I, Antão-Geraldes AM, Leira M, Hernández A, Vasconcelos V, Morais J, Vale M, Raposeiro PM, Gonçalves V, Aleksovski B, Krstić S, Nemova H, Drastichova I, Chomova L, Remec-Rekar S, Elersek T, Delgado-Martín J, García D, Cereijo JL, Gomà J, Trapote MC, Vegas-Vilarrúbia T, Obrador B, García-Murcia A, Real M, Romans E, Noguero-Ribes J, Duque DP, Fernández-Morán E, Úbeda B, Gálvez JÁ, Marcé R, Catalán N, Pérez-Martínez C, Ramos-Rodríguez E, Cillero-Castro C, Moreno-Ostos E, Blanco JM, Rodríguez V, Montes-Pérez JJ, Palomino RL, Rodríguez-Pérez E, Carballeira R, Camacho A, Picazo A, Rochera C, Santamans AC, Ferriol C, Romo S, Soria JM, Hansson LA, Urrutia-Cordero P, Özen A, Bravo AG, Buck M, Colom-Montero W, Mustonen K, Pierson D, Yang Y, M H Verspagen J, de Senerpont Domis LN, Seelen L, Teurlincx S, Verstijnen Y, Lürling M, Maliaka V, Faassen EJ, Latour D, Carey CC, W Paerl H, Torokne A, Karan T, Demir N, Beklioğlu M, Filiz N, E Levi E, Iskin U, Bezirci G, Tavşanoğlu ÜN, Çelik K, Özhan K, Karakaya N, Koçer MAT, Yilmaz M, Maraşlıoğlu F, Fakioglu Ö, Soylu EN, Yağcı MA, Çınar Ş, Çapkın K, Yağcı A, Cesur M, Bilgin F, Bulut C, Uysal R, Köker L, Akçaalan R, Albay M, Alp MT, Özkan K, Sevindik TO, Tunca H, Önem B, Richardson J, Edwards C, Bergkemper V, O'Leary S, Beirne E, Cromie H, Ibelings BW.

Sci Data. 2018 Oct 23;5:180226. doi: 10.1038/sdata.2018.226.

Supplemental Content

Support Center